Centrillion's Research and Development goal is to provide our customers with cost effective approaches for genomic studies and tools of applying genomic information to solve practical problems. Our team of research scientists have many years of experience in developing successful genomic products and have published in leading scientific journals. Our current research focus is on a number of bridging technologies that are critical to large scale genomic studies and are complementary to available technologies. We constantly apply our research results and experience to enhance our genomic service to address… Read More
Centrillion provides standard and custom bioinformatics services for next-gen sequencing and genotyping data. We can help you analyze genomic data quickly and efficiently, building a solution specifically tailored to your research program and in-house capabilities. Here are some examples of our standard analysis pipelines: Exome-Seq QC Exome-Seq reads Align exome reads to reference genome Identify variations (SNPs and short in/dels) Annotate variations Compare to the latest dbSNP Relative position to gene (intron, exon, UTR, coding… Read More
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise empowers our customers to succeed in the most challenging genomic research projects. Contact Us Centrillion Biosciences, Inc. 2438 Embarcadero Way Palo Alto, CA 94303 Tel: (650) 318-3382 Fax: (650) 318-3383 For all general inquiries: info@centrillionbio.com
Palo Alto, CA – Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced a new grant program focused on innovation in the application of next-gen sequencing technology. The Sequencing Innovation Grant award is open to academic, clinical and… Read More
Palo Alto, CA – Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced Dr. Glenn McGall as Senior Vice President of Technology. “I am pleased to announce that Dr. Glenn McGall has joined us as our Senior Vice… Read More
Discover. Publish. Now. Centrillion Biosciences introduces cost effective custom targeted sequencing. You choose the genomic regions of interest for your sample set, we do the rest. You get to move your research forward, faster, on budget. Custom regions up to… Read More